AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 5 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $508,000 | +379.2% | 812,994 | +548.6% | 0.06% | +321.4% |
Q3 2019 | $106,000 | -25.4% | 125,346 | -40.4% | 0.01% | -12.5% |
Q2 2019 | $142,000 | -74.9% | 210,474 | -69.4% | 0.02% | -71.9% |
Q1 2019 | $565,000 | +946.3% | 688,431 | +4583.2% | 0.06% | +1325.0% |
Q3 2017 | $54,000 | – | 14,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer VI & Co. LLC | 675,242 | $2,465,000 | 100.00% |
New Leaf Venture Partners, L.L.C. | 2,340,673 | $8,543,000 | 3.96% |
RA Capital Management | 11,328,646 | $41,350,000 | 3.74% |
NEA Management Company, LLC | 16,362,694 | $59,724,000 | 2.09% |
Avoro Capital Advisors LLC | 4,806,249 | $17,543,000 | 1.36% |
683 Capital Management, LLC | 2,515,810 | $9,183,000 | 0.96% |
SPHERA FUNDS MANAGEMENT LTD. | 1,400,000 | $5,110,000 | 0.73% |
Perceptive Advisors | 6,830,232 | $25,110,000 | 0.48% |
EAM Investors, LLC | 785,338 | $2,866,000 | 0.38% |
Polar Capital LLP | 4,129,238 | $15,072,000 | 0.17% |